Laboratory research material only. Not for human or animal consumption.
Home/Shop/CJC-1295 with DAC 5mg
CJC-1295 with DAC 5mg research peptide vial · Polaris Research

Growth & Sleep · 5mg

CJC-1295 with DAC 5mg

CAS 404050-17-5

$129
1
#8 in monthly peptide rankings
Notify Me When It's Back
Free Express Delivery, No Minimum
Quality Certificate Included
Card, PayPal or PayID
Sealed Under Argon

CJC-1295 with DAC (also written CJC 1295 with DAC, or CJC-1295 DAC) is a long-acting growth-hormone-releasing-hormone analogue studied for the GH/IGF-1 axis and recovery pathways. The DAC, or Drug Affinity Complex, is the modification that extends its half-life, which is what distinguishes this version from the shorter-acting Modified GRF (1-29). It is studied as a reference tool for the growth-hormone-signalling family. The 5mg vial is the standard format.In preclinical and in-vitro research, CJC-1295 with DAC is investigated for how sustained GHRH-analogue signalling influences the GH/IGF-1 axis over a longer window than the unmodified peptide. The extended half-life is the defining research characteristic: it lets investigators study the axis under a more prolonged signal, which is why the DAC version occupies its own place in the literature.Researchers studying the growth-hormone axis often compare the long-acting DAC form with pulsatile approaches; our CJC-1295 + Ipamorelin blend pairs a GHRH analogue with a growth-hormone secretagogue for combination work, and our Art of Pairing library guide covers the rationale behind those pairings. The 5mg vial here is the clean single-compound reference for the long-acting form.Every 5mg vial ships lyophilised with an independently verified batch certificate at a guaranteed floor of ≥98% purity, verifiable on the batch verification page using the batch number on the label. Reconstitute with bacteriostatic water: add it slowly down the inside wall of the vial, swirl gently, and never shake. Store the unopened vial at 2 to 8°C; refrigerate once reconstituted and do not refreeze. CAS reference 404050-17-5.Buying CJC-1295 with DAC in Australia is domestic: free Australia Post Express shipping to all states and territories, no minimum spend, dispatch from within Australia, and tracking on every parcel. Checkout accepts card, PayPal, or PayID, each vial is sealed under argon, and a 24-hour reservation holds your stock from order. Supplied strictly as a research material for lawful laboratory and in-vitro use, not for human or veterinary consumption.

Formal Name
CJC-1295 with DAC
CAS Number
404050-17-5
Purity
99.1% · batch-tested
Description
Long-acting DAC-modified CJC-1295, a GHRH analogue studied for extended GH and IGF-1 signalling.
Research Focus
Long-acting GH/IGF-1 axis and recovery-pathway research.
Suggested Use
Reference plan: 1 mg aliquots on a weekly research cadence.
Doses per Vial
5 x 1 mg reference aliquots.
Concentration
1 mg per reference aliquot from a 5 mg vial.
Notes
Longer exposure profile than non-DAC GHRH analogues; avoid stacking protocols without a clear rationale.
Monthly Ranking

#8 most popular research peptide

View ranking

CJC-1295 + Ipamorelin carries 102 indexed publications, 2 registered trials, 13,450 monthly readers on Wikipedia. Research activity sits at 23 papers in the past twelve months, in line with 0 the year before.

Why It's Searched

Growth hormone axis and sleep-adjacent peptide research searches.

Evidence Standing

102 papers, 23 this year · 2 trials · 13,450 readers (-14%) · A tier

CJC 1295 Ipamorelin AustraliaCJC Ipamorelin blendgrowth peptide researchCJC-1295 with DAC
Updated 2 August 2026

Prepared with care, sealed under argon, and stored at 2–8°C until dispatch. Reconstitute with Bacteriostatic Water before use. Full preparation and storage guidance included with your order.

Independent Research
Evidence Overview on reptides.co

Independent third-party research on reptides.co — not affiliated with Polaris Research. Research reference only, not medical advice.

Pairs Well With

Complete your order

Related Reading

From the library

Also Searched As·CJC-1295 with DAC is also searched as CJC 1295 with DAC, CJC-1295 DAC, Modified GRF (1-29), CJC DAC.

Research File

What has been published on CJC-1295

Accelerating

CJC-1295 appears in 36 indexed publications going back to 2005, including 12 in the past twelve months. No clinical trials are registered on ClinicalTrials.gov.

36
Indexed publications
12
Past 12 months
0
Registered trials
7,222
Monthly readers, down 24%
20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
20151
20163
20170
20180
20192
20201
20211
20223
20231
20241
20251
202611
Read the full CJC-1295 research fileCounts from Europe PMC and ClinicalTrials.gov, refreshed weekly. Reported as a record of what exists, not as evidence of any effect.